Upload
others
View
3
Download
0
Embed Size (px)
Citation preview
Slide 1
Precancerous Oral Conditions in Nevada Adolescents Associated with Tobacco and Marijuana Use
Drs. Marcia Ditmyer*£, Christina Demopoulos£, Connie Mobley£
*Academy for Academic Leadership
£University of Nevada, Las Vegas, School of Dental Medicine
Abstract ID: 306576
November 19, 2014
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 2
All speakers agree that neither they nor members of their immediate family have any financial
relationships with commercial entities that may be relevant to their presentation.
Disclosure Statement
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 3
Learning objectives
1. Describe the history of the Nevada Clean Indoor Air Act and its effect on precancerous oral conditions in Nevada youth.
2. Compare differences and linear associations between oral lesions/enlarged lymph nodes in reported users and non-users of cigarettes/marijuana.
3. Compare oral differences and linear associations between oral lesions/enlarged lymph nodes in reported subjects exposed to environmental tobacco smoke (ETS).
4. Discuss potential interventions to change the environment regarding adolescent cigarette and marijuana use.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 4
Nevada Clean Indoor Air Act
• Nevadans voted on November 7, 2006 to enact the Nevada Clean Indoor Air Act (Question 5) in order to protect themselves and their families from the dangers of ETS.
• Question 5 received over 54 percent of the vote and became law on December 8, 2006.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 5
Nevada Clean Indoor Air Act
• Public/private school buildings and on
public/private school grounds
• Child care facilities with >five children
• All areas of grocery stores, convenience
stores, and drug stores
• All indoor areas within restaurants,
including those in casinos
• Bars, taverns and saloons that serve
food
• Shopping malls and retail stores.
• Video arcades
• Movie theaters
• Government buildings and public places
Smoking tobacco in any form is now prohibited in places like:
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 6
Nevada Clean Indoor Air Act
• During the 2011 legislative session lawmakers passed Assembly Bill 571 which made changes to the voter-approved act.
• Based on these revisions to the statute, stand-alone bars, taverns and saloons in which patrons under 21 years of age are prohibited from entering, may allow smoking.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 7 Tobacco Use
• Tobacco is the leading cause of preventable death worldwide (>5 million per year)
• More than $289 billion a year, including at least $133 billion in direct medical care for adults and more than $156 billion in lost productivity
• In 2012, 18.1% of all adults (42.1 million people): 20.1% of males, 14.5% of females smoked cigarettes
• Tobacco use predicted to kill more than 8 million people worldwide by 2030 and 1 billion by the end of the century.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 8 Lifetime Prevalence of Marijuana Use
• Marijuana use has been linked to adverse health conditions and greater concentrations of carcinogens than tobacco.
Group 2009 2012
8th graders 15.7% 16.4%
10th graders 32.3% 34.5%
12th graders 42.0% 45.5%
College students* 47.5% 46.6%
Young adults (19-28)* 56.0% 56.3%
*Numbers may overlap in results.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 9 Purpose of Study
To determine significant associations between tobacco/marijuana use and precancerous oral conditions (oral lesions and enlarged lymph nodes) in Nevada adolescents.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 10 Background
• Ongoing statewide school-based dental health screening initiative (2002 to 2010) known as Crackdown on Cancer
• Public and private middle and high-schools invited to participate.
• Funded by Master Settlement Agreement allocated to the Trust Fund for Public Health and the Fund for a Healthy Nevada.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 11
Methods
• 31,306 screenings of adolescents between 13-19 from 2006/2010 (The year the Nevada Clean Air Act went into Law)
Year 1 Year 2 Year 3 Year 4
Year and Total
N-value
2006–2007
N = 7,290
2007–2008
N = 7,378
2008–2009
N = 7,064
2009–2010
N = 7,163
n (%) n (%) n (%) n (%)
Total Identified 288 (0.04) 632 (0.09) 365 (0.05) 428 (0.06)
Note: N=1713, with 71 overlapping cases; 826 with oral lesions and 887 with
enlarged lymph nodes.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 12
Methods
• Examinations conducted by licensed/calibrated dentists, hygienists, and dental hygiene students.
• UNLV IRB approved this initiative to assure participant confidentiality and protection.
• Precancerous lesions were defined as any oral lesion and any enlarged lymph nodes not related to known disease.
• Tobacco use and ETS were self-reported.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 13
Methods
•Descriptive (frequency/percentage).
•Percent Change (PC) – when comparing an old value and a new value. Used to see changes from year-to-year.
•Percent Mean Difference (PMD) used to assess differences in percentages within each year on various demographic variables.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 14
RESULTS
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 15 Tobacco and Marijuana Use 2006-2010, By Type
Year 1 Year 2 Year 3 Year 4
Year and Total
N-value
2006–2007
N = 7,290
2007–2008
N = 7,378
2008–2009
N = 7,064
2009–2010
N = 7,163
n (%) n (%) n (%) n (%)
Total Identified 288 (0.04)* 632 (0.09)* 365 (0.05)* 428 (0.06)*
No Tobacco 25 (08.8)** 39 (06.1)** 74 (20.3)** 109 (25.5)**
Tobacco£ 133 (46.1)** 139 (21.9)** 147 (40.3)** 173 (40.4)**
Marijuana 130 (45.1)** 454 (71.8)** 144 (39.4)** 146 (34.1)**
*Percentage of total screened; **Percentage of those identified with
lesions/enlarged lymph nodes; £Tobacco includes cigarettes, cigars, and chew.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 16 Tobacco and Marijuana Use 2006-2010, By Type
2539
74
109133 139 147
173
130
454
144 146
0
50
100
150
200
250
300
350
400
450
500
Year 1 Year 2 Year 3 Year 4
No Tobacco Tobacco£ Marijuana
Significant linear correlation
(p=0.01) between tobacco
use and oral lesions or
enlarged lymph nodes across
the years, with exception in
year 2.
Significant differences in
year 2 between tobacco use
and identified lesions and
lymph nodes (p=0.04)
£ Includes Cigarettes, Chew, and Cigars; Controlled for gender and ETS
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 17 Differences between Males and Females, 2006 - 2010
Year 1 Year 2 Year 3 Year 4
Year and Total
N-value
2006–2007
N = 7,290
2007–2008
N = 7,378
2008–2009
N = 7,064
2009–2010
N = 7,163
n (%) n (%) n (%) n (%)
Total Identified 288 (0.04)* 632 (0.09)* 365 (0.05)* 428 (0.06)*
Males 174 (60.4)** 364 (57.6)** 234 (64.1)** 281 (65.6)**
Females** 114 (39.5)** 265 (41.9)** 131 (35.9)** 145 (33.9)**
*Percentage computed out of the total screened; **Percentage computed from those
identified with lesions/enlarged lymph nodes
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 18 Differences between Males and Females, 2006 - 2010
174
364
234
281
114
265
131145
0
50
100
150
200
250
300
350
400
Year 1 Year 2 Year 3 Year 4
Males Females**
Significant linear correlation
between males/females and
oral lesions or enlarged
lymph nodes (p=0.005).
Significant differences in
years 2 (p=0.001) and 4 (p=-
.01) between males and
females and identified
lesions and lymph nodes.
Controlled for ETS
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 19
ETS Exposure, 2006 - 2010Year 1 Year 2 Year 3 Year 4
Year and Total
N-value
2006–2007
N = 7,290
2007–2008
N = 7,378
2008–2009
N = 7,064
2009–2010
N = 7,163
n (%) n (%) n (%) n (%)
Total Identified 288 (0.04)* 632 (0.09)* 365 (0.05)* 428 (0.06)*
Exposed 179 (62.2)** 603 (95.4)** 192 (52.6)** 234 (54.7)**
Not Exposed 109 (37.8)** 29 (0.05)** 173(47.4)** 194 (45.3)**
*Percentage of total screened; **Percentage of those identified with
lesions/enlarged lymph nodes; SHS exposure was self-reported
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 20 ETS Exposure, 2006-2010
0
100
200
300
400
500
600
700
Year 1 Year 2 Year 3 Year 4
Exposed Not Exposed
No significant correlations
between ETS and oral lesions
or enlarged lymph nodes.
Significant differences in
year 2 between those who
were exposed and those not
exposed to ETS and
identified lesions and lymph
nodes.
Controlled for differences between males and females
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 21
DISCUSSION AND RECOMMENDATIONS
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 22
Discussion
• Approximately 42,440 Americans will be diagnosed with oral or
pharyngeal cancer this year.
• Cause over 8,390 deaths, killing roughly 1 person per hour, 24
hours per day.
• Each year in the United States, more than 21,000 men and 9,000
women are diagnosed with oral cancer. Most are over 60 years
old.
• Because of the HPV Virus, it is becoming more prevalent in
adolescence. Depending on the source – it has or will surpass
tobacco as a risk factor.
Source: National Cancer Institute and CDC, 2014
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 23 Questions to Ask Patients Regarding Tobacco and Marijuana Use
1. Do you use any form of tobacco or marijuana?
2. How much do you use?
a) Tobacco (Number of cigarettes in a day/week)
b) Marijuana (Number of joints in a day/week)
3. How long after you wake up do you have to use tobacco and/or marijuana?
4. Have you ever quit?
a) If so, how long (<30 days, >30 days); what did you do to help you quit?
5. Are you interested in quitting?
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 24 Patient-Centered Counseling ModelStrategies for Behavior Change
1. Motivational Interviewing
2. Stages of Change
3. Payoff Matrix
4. ICR Readiness Ruler
5. 5A’s Model
6. Value Cards
7. Reflective Listening
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 25 Basic Principles of MI Integration
Principles Goals
Express Empathy Build Rapport
Develop Discrepancy Elicit Pros and Cons
Roll with Resistance Respect Patient Autonomy
Support Self-Efficacy Communicate that the patient is
capable of change
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 26 ACTION STEPS
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 27 PAYOFF MATRIX (Example)
Behavior
(Drinking Alcohol)
Alternate Behavior
(Quit Drinking Alcohol)
Pros
Advantages
Helps me relax
Enjoy drinking with friends
Eases boredom and reduces
depression
Feel better physically
Have more $
Less conflict with family, work,
some friends
Cons
Disadvantages
Hard on my health, including
oral health
Spending too much $
Might lose my job
Teeth will look bad and cause
me to be uncomfortable
I’d miss getting that “buzz”
What to do about friends who
drink?
How to deal with stress of not
drinking?
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 28 ICR Readiness Ruler (Example)
• How Important is it for you to change right now?
• How Confident are you that you could do it?
• How Ready are you to change right now?
1 2 3 4 5 6 7 8 9 10
Not at all
Important
Somewhat
Important
Extremely
Important
1 2 3 4 5 6 7 8 9 10
Not at all
Confident
Somewhat
Confident
Extremely
Confident
1 2 3 4 5 6 7 8 9 10
Not at all
Ready
Somewhat
Ready
Extremely
Ready
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 29 5 A’s Model of Behavior Change
1A Assess – current behavior, importance of changing it, self efficacy,
stage of readiness, social support
2A Advise – clear, specific, and personalized behavior change, including
information about personal health harms/benefits.
3A Agree – collaboratively on the behavior to target (may be several),
next steps based on stage of readiness
4A Assist – self-help and/or counseling including goal setting and action
planning to develop skills, confidence, support to achieve goals
5A Arrange – follow-up (in person or by telephone) to discuss progress,
barriers, adjusting plan
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 30
Discussion!
1. What do you think the impact on oral health might be with the legalization of marijuana?
2. How can healthcare providers better address the risk of non-traditional risk factors for oral cancer (i.e., Hookah, HPV, marijuana, e-cigarettes etc.) as they are growing trends in adolescents?
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 31 References
• Axelsson, P., Paulander, J., Lindhe, J. (1998). Relationship between smoking and dental
status in 35, 50-, 65-, and 75-year-old individuals. Journal of Clinical Periodontology, 25,
297-305.
• Boulos, D. N. K., Loffredo, C. A., Setouhy, M. E., Abdel-Aziz, F., Israel, E., & Mohamed, M.
K. Nondaily, light daily, and moderate-to-heavy cigarette smokers in a rural area of Egypt:
A population-based survey. Nicotine & Tobacco Research, 11(2), 134-138. doi:
10.1093/ntr/ntp016
• Centers for Disease Control and Prevention [CDC]. (2002). Annual smoking-attributable
mortality, years of potential life lost, and economic costs—United States, 1995–1999.
Morbidity and Mortality Weekly Report, 51(14), 300–303. Retrieved from
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5114a2.htm
• Centers for Disease Control and Prevention [CDC]. (2008). Smoking-attributable mortality,
years of potential life lost, and productivity losses—United States, 2000–2004. Morbidity
and Mortality Weekly Report. 57(45), 1226–1228. Retrieved from
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5745a3.htm
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 32
References
• Ditmyer, M. M., Mobley, C., Draper, Q., Demopoulos, C., & Smith, E.S. (2008).
Development of a theoretical screening tool to assess caries risk in Nevada youth. Journal
of Public Health Dentistry, 68(4), 201-208. doi: 10.1111/j.1752-7325.2007.00066.x
• Gilpin, E. A., White, M. M, Farkas, A. J., & Pierce, J. P. (1999). Home smoking restrictions:
Which smokers have them and how they are associated with smoking behavior. Nicotine
and Tobacco Research, 1(2):153-162. doi: 10.1080/14622299050011261
• Healthy People 2020. (2011). 2020 Topics and Objectives. Retrieved
fromhttp://healthypeople.gov/2020/topicsobjectives2020/default.aspx
• Johnston, L. D., O’Malley, P. M., Bachman, J.G., & Schulenberg, J.E. (2011). Monitoring
the Future National Results on Adolescent Drug Use: Overview of Key Findings, 2010. Ann
Arbor: Institute for Social Research, The University of Michigan.
• National Institute on Drug Abuse [NIDA]. (2011). Info Facts: High School and Youth Trends.
• National Institutes of Health, US Department of Health and Human Services. Retrieved
from www.nida.nih.gov/infofacts/hsyouthtrends.html
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 33
References• Johnston, L. D., O’Malley, P. M., Bachman, J.G., & Schulenberg, J.E. (2011). Monitoring the Future
National Results on Adolescent Drug Use: Overview of Key Findings, 2010. Ann Arbor: Institute for
Social Research, The University of Michigan.
• National Institute on Drug Abuse [NIDA]. (2011). Info Facts: High School and Youth Trends.
• National Institutes of Health, US Department of Health and Human Services. Retrieved from
www.nida.nih.gov/infofacts/hsyouthtrends.html
• Shenkin, J. D., Broffitt, B., Levy, S., Warren, J.J. (2004). The association between environmental
tobacco smoke and primary tooth caries. Journal of Public Health Dentistry, 64(3), 184-186.
• U.S. Department of Health and Human Services [USDHHS]. (2007). Trends in Oral Health Status:
United States, 1988-1944 and 1999 to 2004. Preliminary Report. Vital and Health Statistics,
11(248). DHHS Publication No. (PHS) 2007-1698, Hyattsville, MD.
• World Health Organization (WHO). (2011a). WHO Report on the global tobacco epidemic 2009,
Implementing Smoke-free environments: Executive Report. Retrieved from
http://whqlibdoc.who.int/hq/2009/WHO_NMH_TFI_09.1_eng.pdf
• World Health Organization (WHO). (2011b). Prevalence in tobacco use. Retrieved from
http://www.who.int/gho/tobacco/use/en/
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
Slide 34
Questions ??
Acknowledgments
Source of Funding: Crackdown on Cancer Oral Health Surveillance Screening
Program receives funding through the Trust Fund for Public Health and The Fund
for Healthy Nevada, both beneficiaries of the Master Tobacco Settlement.
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________
___________________________________